NM-2-AI

NM-2-AI
Clinical data
Other names	NM2AI; N-Methyl-2-aminoindane; N-Methyl-2-AI; N-Methyl-AI; AM-80; Methaminoindan; Methoaminoindane
Drug class	Norepinephrine releasing agent; Stimulant
ATC code	None;
Legal status
Legal status	DE: NpSG (Industrial and scientific use only); UK: Under Psychoactive Substances Act;
Identifiers
	IUPAC name N-Methyl-2,3-dihydro-1H-inden-2-amine;
CAS Number	24445-44-1; HCl: 10408-85-2;
PubChem CID	15023225;
ChemSpider	13566342;
UNII	ZLW84Y27HG;
ChEMBL	ChEMBL1188235;
CompTox Dashboard (EPA)	DTXSID901010100 ;
Chemical and physical data
Formula	C10H13N
Molar mass	147.221 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CNC2CC1=CC=CC=C1C2;
	InChI InChI=1S/C10H13N/c1-11-10-6-8-4-2-3-5-9(8)7-10/h2-5,10-11H,6-7H2,1H3; Key:SXWZQUCTTOBHJT-UHFFFAOYSA-N;

NM-2-AI, or NM2AI, also known as N-methyl-2-aminoindane, is a stimulant of the 2-aminoindane family that has been sold online as a designer drug. It is a rigid analogue of methamphetamine. NM-2-AI acts as a selective norepinephrine releasing agent, but also has affinity for several monoamine receptors.